His main research concerns Prostate cancer, Internal medicine, Prostatectomy, Prostate and Prostate-specific antigen. William J. Aronson has researched Prostate cancer in several fields, including Cancer research and Cohort. As part of one scientific family, William J. Aronson deals mainly with the area of Internal medicine, narrowing it down to issues related to the Endocrinology, and often Apoptosis, Cell growth and Insulin-like growth factor.
His Prostatectomy research includes elements of Surgery, Proportional hazards model, Biopsy and Urology. His Prostate research is multidisciplinary, incorporating perspectives in Testosterone, Physical exercise, Growth factor and Oncology. His research in Prostate-specific antigen intersects with topics in Metabolite, Prostate biopsy, Gynecology, Pharmacology and Risk factor.
The scientist’s investigation covers issues in Prostate cancer, Prostatectomy, Internal medicine, Oncology and Biochemical recurrence. William J. Aronson interconnects Prostate, Retrospective cohort study, Cohort and Hazard ratio in the investigation of issues within Prostate cancer. The concepts of his Prostatectomy study are interwoven with issues in Prostate-specific antigen, Biopsy, Proportional hazards model and Urology.
His biological study spans a wide range of topics, including Nephrology, Predictive value of tests, Stage, Risk factor and Doubling time. He has included themes like Endocrinology and Gynecology in his Internal medicine study. His Biochemical recurrence research incorporates themes from Surgery, Multivariate analysis, Nomogram, breakpoint cluster region and Adjuvant therapy.
His primary scientific interests are in Prostate cancer, Internal medicine, Prostatectomy, Oncology and Hazard ratio. His Prostate cancer research integrates issues from Metastasis, Proportional hazards model and Veterans Affairs. His Internal medicine study frequently draws connections to adjacent fields such as Endocrinology.
Many of his research projects under Prostatectomy are closely connected to Database with Database, tying the diverse disciplines of science together. His research investigates the connection between Hazard ratio and topics such as Absolute risk reduction that intersect with problems in Relative risk and Pathologic fracture. His research in Body mass index focuses on subjects like Obesity, which are connected to Lower risk and Prostate-specific antigen.
His scientific interests lie mostly in Prostate cancer, Prostatectomy, Internal medicine, Hazard ratio and Androgen deprivation therapy. His studies deal with areas such as Prostate, Oncology, Urology, Randomized controlled trial and Cohort as well as Prostate cancer. In the field of Prostatectomy, his study on Biochemical recurrence overlaps with subjects such as Database.
His Internal medicine study frequently draws connections between adjacent fields such as Endocrinology. As a part of the same scientific family, William J. Aronson mostly works in the field of Hazard ratio, focusing on Proportional hazards model and, on occasion, Bone metastasis, Metastasis, Bone pain and Veterans Affairs. His work on Castration Resistance as part of general Androgen deprivation therapy study is frequently linked to Fish oil, therefore connecting diverse disciplines of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Radical Prostatectomy versus Observation for Localized Prostate Cancer
Timothy J. Wilt;Michael K. Brawer;Karen M. Jones;Michael J. Barry.
The New England Journal of Medicine (2012)
Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission
Jacob Rajfer;William J. Aronson;Peggy A. Bush;Frederick J. Dorey.
The New England Journal of Medicine (1992)
Intensive lifestyle changes may affect the progression of prostate cancer.
Dean Ornish;Gerdi Weidner;William R. Fair;Ruth Marlin.
The Journal of Urology (2005)
Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer
Allan J. Pantuck;John T. Leppert;Nazy Zomorodian;William Aronson.
Clinical Cancer Research (2006)
Impact of Obesity on Biochemical Control After Radical Prostatectomy for Clinically Localized Prostate Cancer: A Report by the Shared Equal Access Regional Cancer Hospital Database Study Group
Stephen J. Freedland;William J. Aronson;Christopher J. Kane;Joseph C. Presti.
Journal of Clinical Oncology (2004)
Follow-up of Prostatectomy versus Observation for Early Prostate Cancer
Timothy J. Wilt;Karen M. Jones;Michael J. Barry;Michael J. Barry;Gerald L. Andriole.
The New England Journal of Medicine (2017)
Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.
Lionel L. Bañez;Robert J. Hamilton;Robert J. Hamilton;Alan W. Partin;Robin T. Vollmer.
The Correlation Between Metabolic Syndrome and Prostatic Diseases
Cosimo De Nunzio;William Aronson;Stephen J. Freedland;Edward Giovannucci.
European Urology (2012)
Pomegranate Ellagitannin-Derived Metabolites Inhibit Prostate Cancer Growth and Localize to the Mouse Prostate Gland
Navindra P. Seeram;William J. Aronson;Yanjun Zhang;Susanne M. Henning.
Journal of Agricultural and Food Chemistry (2007)
Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy
Stephen J Freedland;Mark E Sutter;Frederick Dorey;William J Aronson;William J Aronson.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: